N Concordance 1 er Institute to have an autologous bone marrow transplant for multiple myeloma. 2 pment of psoriasis after syngeneic bone marrow transplant from psoriatic donor: 3 ued interferon alfa vs allogeneic bone marrow transplant vs autologous peripher 4 SPLANTATION Patients who have a bone marrow transplant face an increased risk 5 se association with survival after bone marrow transplant when other clinical fa 6 kemia Not eligible for allogeneic bone marrow transplant from related donor 7 lymphoblastic leukemia received a bone marrow transplant (BMT) from an HLA-iden 8 second remission of childhood ALL, bone marrow transplant is superior to chemoth 9 = 23). Of 215 recipients without a bone marrow transplant in the induction group 10 -dose chemotherapy and autologous bone marrow transplant because selected phase 11 tly described occurrence of WMS in bone marrow transplant patients presenting wi 12 Previous autologous stem cell or bone marrow transplant is allowed provided 13 having to explain not only what a bone marrow transplant is, which is very com 14 the marrow that was destroyed. A bone marrow transplant using marrow from a re